ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $401,000 | -72.5% | 16,447 | -83.9% | 0.16% | -79.4% |
| Q4 2018 | $1,458,000 | -14.9% | 102,345 | -9.2% | 0.77% | +1.2% |
| Q3 2018 | $1,713,000 | +25.4% | 112,700 | +38.4% | 0.76% | +28.7% |
| Q2 2018 | $1,366,000 | +17.3% | 81,416 | +14.0% | 0.59% | +36.1% |
| Q1 2018 | $1,165,000 | +79.8% | 71,400 | +41.1% | 0.44% | +119.7% |
| Q4 2017 | $648,000 | -42.1% | 50,600 | -44.4% | 0.20% | -41.6% |
| Q3 2017 | $1,119,000 | +59.6% | 91,000 | +8.7% | 0.34% | +71.2% |
| Q2 2017 | $701,000 | +183.8% | 83,700 | +197.9% | 0.20% | +94.1% |
| Q4 2016 | $247,000 | +263.2% | 28,100 | +181.0% | 0.10% | +308.0% |
| Q3 2016 | $68,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|